首页> 外文期刊>Expert review of anti-infective therapy >Treatment of neurobrucellosis: what is known and what remains to be answered.
【24h】

Treatment of neurobrucellosis: what is known and what remains to be answered.

机译:神经布鲁氏菌病的治疗:已知和尚待解决的问题。

获取原文
获取原文并翻译 | 示例
       

摘要

Neurological involvement is one of the most perplexing and diverse presentation complications of brucellosis, a worldwide prevalent zoonosis. This review presents the current knowledge available from medical literature and discusses the shortcomings of the existing data. A proposed regimen should include doxycycline and rifampicin and, with the benefit of doubt, ceftriaxone, since its high concentration in the cerebrospinal fluid may offer significant efficacy against the pathogen. Corticosteroids have been used in specialized situations. The use of streptomycin is discouraged owing to its questionable ability to penetrate into the cerebrospinal fluid and its potential neurotoxicity that may perplex the clinical presentation. Treatment duration should be individualized in the absence of an adequate cut-off index.
机译:神经系统疾病是布鲁氏菌病(全世界流行的人畜共患病)中最令人困惑和多样化的表现并发症之一。这篇综述介绍了可从医学文献中获得的当前知识,并讨论了现有数据的缺点。提议的治疗方案应包括强力霉素和利福平,还有头孢曲松,这无疑是有益的,因为它在脑脊髓液中的高浓度可能对病原体具有显着的功效。皮质类固醇已用于特殊情况。不推荐使用链霉素,因为链霉素渗透脑脊液的能力令人怀疑,并且其潜在的神经毒性可能使临床表现困惑。在没有足够的临界值的情况下,治疗时间应个体化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号